KalGene Pharmaceuticals
KalGene specializes in converting promising oncology research into prescribable personalized medicine. KalGene Pharmaceuticals Inc. is a privately-held Canadian company focused on the development of oncology therapeutics and companion diagnostics. The company's product pipeline is at various stages of research and development. Its oncology programs are aimed at improving clinical and survival outcomes through the use of personalized medicine, with a particular focus on breast, bladder, epithelial and thyroid cancers. KalGene is partnering with many of North America’s leading clinician-scientists and academic institutions to deliver personalized cancer diagnostics and drugs that maximize positive patient treatment outcomes.
Pipeline at KalGene
Therapeutics and Companion Diagnostics
 

 

Contact Dr. T. Nathan Yoganathan (nathan@kalgene.com) for the latest Kalgene news.

 

  
Contact KalGene
 

Dr. T. Nathan Yoganathan
President and CSO
Email: nathan@kalgene.com

 

Vancouver Office:
2386 East Mall, Unit #200
Vancouver, BC
Canada V6T 1Z3
Phone: 604.375.4519

 

Toronto Office:
MaRS Centre, South Tower
101 College St., 2nd Floor, Suite 200
Toronto, ON, Canada M5G 1L7
Phone: 416.876.0270

 

 

©2011 Kalgene Pharmaceuticals Inc. All Rights Reserved


return to top